← Insider buys
ZYME

Zymeworks Inc. · Healthcare

Ecor1 Capital, LLC bought $5.3M of Zymeworks Inc.

Director and 10% owner

Bought$5,321,176
$14.64Price
363,369Shares
+2%Stake

What ZYME did for a copier

Filed Jan 2Copier in Jan 3
$1,000 copied at Fri, Jan 3 open, $16.46
$900
S&P 500, same days
+4.3%

Measured over 30 trading days, to the Feb 19 close.

Ecor1 Capital, LLC's record

24 other buys with 3 months of prices since 2020: on average −5.1% against the S&P 500, and 8 of 24 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Dec 30. Filed Thu, Jan 2. Returns use the Jan 3 open and the Feb 19 close. Not investment advice.